InsidersTradesSigma
Track the 팬젠 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 팬젠 has recorded 4 reports. Market capitalisation: €67.5bn. The latest transaction was filed on 24 April 2026 (Sale). Among the most active insiders: 오한규. The full history is free.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
4 ops.
Sell Volume
Fundamental score
Ranked 14,580 of 29,156 companies
52.0
score / 100
Value38
Quality66
FCF yld-0.8%
Earn yld3.0%
EV/EBITDA18.6x
ROE7.3%
Gross mgn34%
Net mgn15%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 April 2026
About 팬젠
팬젠 is a company in the health and pharmaceutical sector listed on the XKRX market. It specializes in the development of biopharmaceutical solutions.